ʻO nā mea noiʻi ma ke kula ʻo Icahn School of Medicine ma Mount Sinai (Icahn Mount Sinai), New York City, a me Reproductive Medicine Associates o New York (RMA o New York) ua hoʻohālikelike i nā helu o ka fertilization, ka hāpai ʻana, a me ka hāʻule mua ʻana i nā maʻi IVF i loaʻa ʻelua. nā ʻano o nā lāʻau lapaʻau i hana ʻia e Pfizer a i ʻole Moderna me nā hopena like i nā maʻi maʻi ʻole.
ʻO ka haʻawina e pili ana i nā poʻe maʻi i hōʻiliʻili ʻia nā hua mai nā ovaries a i hoʻomoʻa ʻia e ka sperm i loko o kahi keʻena hana, e hana ana i nā embryos i paʻa i ka hau a ma hope thawed a hoʻoili ʻia i ka ʻōpū, a me nā mea maʻi i mālama i ka lāʻau lapaʻau e hoʻoulu i ka ulu ʻana o nā hua. ʻO nā pūʻulu ʻelua o nā maʻi i hoʻoili ʻia i ka embryo hoʻoheheʻe i hoʻoheheʻe ʻia-214 i hoʻopaʻa ʻia a me 733 ʻaʻole i hoʻopaʻa ʻia-ua like nā helu o ka hāpai ʻana a me ka nalowale ʻana o ka hāpai ʻana. ʻO nā pūʻulu ʻelua o nā maʻi i hoʻoulu ʻia i ka ovarian stimulation—222 i hoʻopaʻa ʻia a me 983 i hoʻopaʻa ʻole ʻia-ua like nā helu o nā hua i kiʻi ʻia, fertilization, a me nā embryos me nā helu maʻamau o nā chromosomes, ma waena o nā ana ʻē aʻe.
Manaʻo nā mea kākau o ka noiʻi e hōʻoluʻolu nā ʻike i ka hopohopo o ka poʻe e noʻonoʻo ana i ka hāpai ʻana. "Ma ka hoʻohana ʻana i ka ʻepekema a me ka ʻikepili nui, hiki iā mākou ke kōkua i ka hōʻoluʻolu i nā poʻe maʻi o ka makahiki hānau a hiki iā lākou ke hana i nā hoʻoholo maikaʻi loa no lākou iho. E hōʻoluʻolu ka poʻe i ka ʻike ʻana ʻaʻole pili ka lāʻau lapaʻau COVID-19 i ko lākou hiki ke hānau keiki, "wahi a ka mea kākau kiʻekiʻe ʻo Alan B. Copperman, MD, FACOG, ka luna hoʻomalu a me ke kauka lapaʻau o ka obstetrics, gynecology a me ka ʻepekema reproductive ma Icahn Mount Sinai a. ka luna o RMA o New York, ka mea i ʻike ʻia ma ke ao holoʻokoʻa ma ke ʻano he kikowaena alakaʻi o ka lāʻau lapaʻau hānau.
Ua mālama ʻia nā poʻe maʻi i loko o ka noiʻi ma RMA o New York ma waena o Pepeluali a me Kepakemapa 2021. ʻO nā mea maʻi e mālama ana i ka mālama IVF e nānā pono ʻia, e hiki ai i nā mea noiʻi ke hopu i ka ʻikepili mua e pili ana i ka hoʻokomo ʻana o nā embryos i ka hoʻohui ʻana i nā nalowale o ka hāpai ʻana i hiki ke helu ʻia i nā haʻawina ʻē aʻe. .
Hoʻopili ka paʻi ʻana o ka noiʻi hou me ka piʻi ʻana o ka ʻano like ʻole o Omicron. Ua ʻike ʻia nā noiʻi mua ua kōkua ka lāʻau lapaʻau COVID-19 i ka pale ʻana i ka poʻe hāpai - no lākou ka COVID-19 i hoʻonui nui i ka pilikia o ka maʻi koʻikoʻi a me ka make - mai ka maʻi koʻikoʻi, hāʻawi i nā antibodies i kā lākou pēpē, a ʻaʻole i hoʻonui i ka pilikia o ka hānau mua ʻana a i ʻole ka fetal. pilikia ulu.
He aha e lawe ʻia mai kēia ʻatikala:
- ʻO nā mea noiʻi ma ke kula ʻo Icahn School of Medicine ma Mount Sinai (Icahn Mount Sinai), New York City, a me Reproductive Medicine Associates o New York (RMA o New York) ua hoʻohālikelike i nā helu o ka fertilization, ka hāpai ʻana, a me ka hāʻule mua ʻana i nā maʻi IVF i loaʻa ʻelua. nā ʻano o nā lāʻau lapaʻau i hana ʻia e Pfizer a i ʻole Moderna me nā hopena like i nā maʻi maʻi ʻole.
- The study involved patients whose eggs were collected from the ovaries and fertilized by sperm in a laboratory, creating embryos that were frozen and later thawed and transferred to the womb, and patients who underwent medical treatment to stimulate the development of eggs.
- Copperman, MD, FACOG, division director and clinical professor of obstetrics, gynecology and reproductive science at Icahn Mount Sinai and director of RMA of New York, which is recognized internationally as a leading center of reproductive medicine.
